Hologic, Inc. - Common Stock (NQ:HOLX)

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...

March 04, 2026

As of March 4, 2026, the global financial landscape is witnessing a seismic shift in corporate strategy. After years of cautious maneuvering and high interest rates, the "animal spirits" of the...

The Return of the Titans: M&A Volume Set to Surge 20% in 2026 Amidst "Animal Spirits"

March 04, 2026

HOLOGIC INC (NASDAQ:HOLX) Reports Q1 2026 Revenue and Earnings Miss Amid Pending Merger ↗

Topics Artificial Intelligence Economy World Trade

January 29, 2026

Via Chartmill

Topics Earnings

3 Cash-Producing Stocks We Find Risky

February 25, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Though Hologic has outperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Is Wall Street Bullish or Bearish on Hologic Stock?

February 10, 2026

Via Barchart.com

Topics ETFs

Earnings To Watch: QuidelOrtho (QDEL) Reports Q4 Results Tomorrow

February 09, 2026

Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) will be reporting earnings this Wednesday after the bell. Here’s what to expect.

The "Great Hesitation" in global finance has officially come to an end. In the opening weeks of 2026, the private equity landscape has undergone a dramatic transformation, shifting from two years of...

Topics World Trade

The Return of the Giants: Private Equity Mega-Deals Surge in Early 2026

February 05, 2026

Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) will be announcing earnings results this Wednesday before market hours. Here’s what investors should know.

Topics Artificial Intelligence Economy Initial Public Offering

GE HealthCare (GEHC) Q4 Earnings Report Preview: What To Look For

February 02, 2026

Medical technology company Hologic (NASDAQ:HOLX) missed Wall Street’s revenue expectations in Q4 CY2025 as sales rose 2.5% year on year to $1.05 billion. Its non-GAAP profit of $1.04 per share was 5.4%...

Topics Artificial Intelligence

Hologic (NASDAQ:HOLX) Misses Q4 CY2025 Revenue Estimates

January 29, 2026

The US credit market has entered 2026 with a level of momentum unseen in nearly a decade, as a powerful combination of multi-billion dollar mergers and a resurgence in leveraged buyouts (LBOs) drives...

US Credit Market: M&A and LBOs Fuel Issuance Surge in 2026

January 28, 2026

Medical technology company Hologic (NASDAQ:HOLX) will be reporting earnings this Thursday after market hours. Here’s what you need to know.

Topics Artificial Intelligence Bonds Economy

Hologic (HOLX) Q4 Earnings: What To Expect

January 27, 2026

As of January 23, 2026, the global financial landscape is witnessing what many analysts are calling a structural "renaissance" in private equity. Led by industry titans Blackstone (NYSE: BX) and KKR &...

Topics Artificial Intelligence

The Breaking of the Deal Dam: Inside the Private Equity Renaissance of 2026

January 23, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have...

Topics Artificial Intelligence Economy Energy

1 Healthcare Stock Worth Investigating and 2 That Underwhelm

January 15, 2026

The "exit logjam" that defined the global financial landscape for nearly three years has officially broken. As of January 15, 2026, the private equity (PE) and venture capital (VC) markets are...

Topics Stocks

The Great Unlocking: Private Equity and Venture Capital Exits Surge as 2026 Begins

January 15, 2026

The Great Diagnostic Consolidation: How a $25.7 Billion Mega-Deal Ignited a 150% Surge in Healthcare M&A

Topics Artificial Intelligence Economy Initial Public Offering

January 14, 2026

As 2026 begins, the healthcare sector is undergoing its most profound transformation in decades. Driven by a relentless push toward "precision medicine" and the industrialization of artificial...

Hologic is scheduled to release its first-quarter results soon, with analysts projecting single-digit growth in its bottom line figure.

Topics Artificial Intelligence

What You Need To Know Ahead of Hologic's Earnings Release

January 08, 2026

Via Barchart.com

Topics ETFs

3 Unpopular Stocks We Find Risky

December 29, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

With margins holding firm, cash piling up, and AI services quietly compounding, this buy looks less like a quick trade and more like a conviction call hiding in plain sight.

Why One Fund Made an $11 Million Bet on TaskUs Despite a Steep 32% Stock Drop ↗

December 28, 2025

Why a $7.3 Million Bet on Core Scientific Looked Smart at Quarter-End but Got Tested 30% Later ↗

Topics Artificial Intelligence Economy

December 28, 2025

A deal collapse rewrote the stock’s near-term narrative, so the story has changed quite a bit since quarter-end.

Spotting Winners: Hologic (NASDAQ:HOLX) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q3

December 24, 2025

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - imaging, diagnostics stocks, including Hologic (NASDAQ:HOLX) and its peers.

The Baidu position now represents 4.93% of AUM, placing it outside the fund's top five holdings.

Topics Artificial Intelligence

Black Creek Dumps 999,000 Shares of Baidu Stock Worth $49.1 Million ↗

December 17, 2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Topics Artificial Intelligence Economy

1 S&P 500 Stock Worth Your Attention and 2 We Avoid

December 15, 2025

While Hologic has underperformed the Nasdaq over the past year, it has notably outperformed in recent months, but analysts still remain cautious about the stock’s prospects.

Topics Economy Stocks

Is Hologic Stock Outperforming the Nasdaq?

December 12, 2025

Via Barchart.com

Topics Stocks World Trade

3 Cash-Producing Stocks We Approach with Caution

December 11, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.

How Is The Market Feeling About Hologic Inc? ↗

December 08, 2025

Via Benzinga

1 Mooning Stock on Our Watchlist and 2 Facing Headwinds

December 07, 2025

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract...

1 Mid-Cap Stock Worth Investigating and 2 We Turn Down

November 23, 2025

Black Creek’s Stake Reduction and the Larger Transition Unfolding Inside NICE’s Cloud and AI Platform ↗

Topics Supply Chain

November 21, 2025

NICE sits at the center of two critical enterprise markets: customer experience and financial crime prevention. This piece breaks down what is changing inside the business and why its next phase of...

Over the past six months, Hologic has been a great trade, beating the S&P 500 by 20%. Its stock price has climbed to $74.17, representing a healthy 31.3% increase. This was partly due to its solid...

Topics Artificial Intelligence Regulatory Compliance

3 Reasons HOLX is Risky and 1 Stock to Buy Instead

November 19, 2025